Stockscreener 앱 받기
3.03
1.67%
0.04
전일 마감가:
$2.99
열려 있는:
$3
하루 거래량:
6,667
Relative Volume:
0.03
시가총액:
$59.29M
수익:
-
순이익/손실:
$-30.15M
주가수익비율:
-0.7575
EPS:
-4
순현금흐름:
$-21.66M
1주 성능:
+1.00%
1개월 성능:
-1.94%
6개월 성능:
+3.75%
1년 성능:
+25.62%
1일 변동 폭
$2.99
$3.10
1주일 범위
$2.89
$3.10
52주 변동 폭
$1.10
$6.01
Nrx Pharmaceuticals Inc Stock (NRXP) Company Profile
명칭
Nrx Pharmaceuticals Inc
전화
484-254-6134
주소
1201 ORANGE STREET, WILMINGTON
NRXP을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
NRXP
Nrx Pharmaceuticals Inc
|
3.04 | 60.66M | 0 | -30.15M | -21.66M | -4.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
476.21 | 119.21B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.05 | 59.16B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
327.00 | 40.57B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
574.20 | 34.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
295.35 | 29.19B | 3.81B | -644.79M | -669.77M | -6.24 |
Nrx Pharmaceuticals Inc Stock (NRXP) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-04-02 | 개시 | BTIG Research | Buy |
Nrx Pharmaceuticals Inc 주식(NRXP)의 최신 뉴스
What drives NRx Pharmaceuticals Inc. Equity Warrant stock priceHigh-yield capital appreciation - jammulinksnews.com
NRx Pharmaceuticals Inc. Equity Warrant Stock Analysis and ForecastRapidly growing investment returns - jammulinksnews.com
What analysts say about NRx Pharmaceuticals Inc. stockBreakout stock performance - jammulinksnews.com
NRx Pharmaceuticals Inc. Stock Analysis and ForecastFree Trend-Following Techniques - Autocar Professional
Is NRx Pharmaceuticals Inc. Equity Warrant a good long term investmentConsistent high-performance stocks - Autocar Professional
What drives NRx Pharmaceuticals Inc. stock priceBreakout stock performance - jammulinksnews.com
What analysts say about NRx Pharmaceuticals Inc. Equity Warrant stockFree High-Return Strategy Alerts - jammulinksnews.com
NRx Pharmaceuticals' Dual-Path Strategy for NRX-100: A Game-Changer in Suicidal Depression Treatment - AInvest
IBN Coverage: NRx Pharmaceuticals (NASDAQ: NRXP) Charts Dual-Path for NRX-100 - Yahoo Finance
NRx Pharmaceuticals (NASDAQ: NRXP) Charts Dual-Path for NRX-100 - TipRanks
Is NRx Pharmaceuticals Inc. a good long term investmentBreakthrough profits - Autocar Professional
Rockford Register Star: Local News, Politics & Sports in Rockford, IL - FinancialContent
NRx Pharmaceuticals (NASDAQ: NRXP) Positioning at the Forefront of Next-Gen Treatment - The Globe and Mail
NRx Pharmaceuticals: Pioneering Mental Health Innovation Through Clinical and Operational Synergy - AInvest
IBN Coverage: NRx Pharmaceuticals (NASDAQ: NRXP) Positioning at the Forefront of Next-Gen Treatment - Yahoo Finance
NRx Pharmaceuticals (NASDAQ: NRXP) Positioning At The Forefront Of Next-Gen Treatment - Barchart.com
NRx Pharmaceuticals (NASDAQ: NRXP) Subsidiary to Acquire 49% Stake in Prominent Florida Neuropsychiatry Clinic - The Globe and Mail
IBN Coverage: NRx Pharmaceuticals (NASDAQ: NRXP) Subsidiary to Acquire 49% Stake in Prominent Florida Neuropsychiatry Clinic - Yahoo Finance
Nrx Pharmaceuticals shares rise 1.23% after-hours after being added to Russell Microcap Growth Index. - AInvest
HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announce Agreement to Acquire Interest in Cohen and Associates, LLC for HOPE's Network of Interventional Psychiatry Clinics - Eastern Progress
NRx Pharmaceuticals (NASDAQ: NRXP) Subsidiary HOPE Therapeutics to Acquire 49% Stake in Leading Florida Psychiatry Clinic - The Globe and Mail
IBN Initiates Coverage of NRx Pharmaceuticals Inc. - GlobeNewswire
NRXP: Analyst Maintains 'Buy' Rating with Target Price Firm at $31 | NRXP Stock News - GuruFocus
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announces Filing of Commissioner's National Priority Voucher Application for Intravenous Ketamine (NRX-100) - Nasdaq
New FDA Fast-Track Program Could Accelerate Ketamine Depression Drug Approval by 10 Months - Stock Titan
New to The Street Show #673 Airs Nationwide on Bloomberg TVSaturday, June 21 at 6:30 PM EST Featuring FLOKI, NRX Pharmaceuticals (NASDAQ:NRXP), MUSQThe Music ETF (NYSE:MUSQ), Health In Tech (NASDAQ:HIT), and Vita Bella - Detroit Free Press
New to The Street's Show #672 Airs Tonight on Fox Business Network at 10:30 PM EST - The Joplin Globe
NRx Pharmaceuticals (NASDAQ: NRXP) Forms Investor Relations Partnership With astr Partners - financial-news.co.uk
NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) and HOPE Therapeutics, Inc. Announce Strategic Investor Relations Partnership with astr partners - StreetInsider
NRx Pharmaceuticals Taps Top Biotech IR Firm ahead of Critical FDA Filings and Clinic Acquisitions - Stock Titan
Nrx Pharmaceuticals Inc (NRXP) 재무 분석
매출
순이익
현금흐름
주당 순 이익
4.50%
0.12%
자본화:
|
볼륨(24시간):